These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32927030)

  • 1. Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor.
    Taoda Y; Miyagawa M; Akiyama T; Tomita K; Hasegawa Y; Yoshida R; Noshi T; Shishido T; Kawai M
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127547. PubMed ID: 32927030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent Endonuclease.
    Miyagawa M; Akiyama T; Taoda Y; Takaya K; Takahashi-Kageyama C; Tomita K; Yasuo K; Hattori K; Shano S; Yoshida R; Shishido T; Yoshinaga T; Sato A; Kawai M
    J Med Chem; 2019 Sep; 62(17):8101-8114. PubMed ID: 31386363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel 5-hydroxy-4-pyridone-3-carboxy acids as potent inhibitors of influenza Cap-dependent endonuclease.
    Miyagawa M; Akiyama T; Mikamiyama-Iwata M; Hattori K; Kurihara N; Taoda Y; Takahashi-Kageyama C; Kurose N; Mikamiyama H; Suzuki N; Takaya K; Tomita K; Matsuo K; Morimoto K; Yoshida R; Shishido T; Yoshinaga T; Sato A; Kawai M
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4739-4742. PubMed ID: 27568084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship studies of anti-bunyaviral cap-dependent endonuclease inhibitors.
    Taoda Y; Sato A; Toba S; Unoh Y; Kawai M; Sasaki M; Orba Y; Sawa H
    Bioorg Med Chem Lett; 2023 Mar; 83():129175. PubMed ID: 36758821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.
    Baughman BM; Jake Slavish P; DuBois RM; Boyd VA; White SW; Webb TR
    ACS Chem Biol; 2012 Mar; 7(3):526-34. PubMed ID: 22211528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonuclease.
    Rogolino D; Naesens L; Bartoli J; Carcelli M; De Luca L; Pelosi G; Stokes RW; Van Berwaer R; Vittorio S; Stevaert A; Cohen SM
    Bioorg Chem; 2021 Nov; 116():105388. PubMed ID: 34670331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-chelating p-phenylidene-linked bis-imidazoline analogs of known influenza virus endonuclease inhibitors: Synthesis and anti-influenza activity.
    Dar'in D; Zarubaev V; Galochkina A; Gureev M; Krasavin M
    Eur J Med Chem; 2019 Jan; 161():526-532. PubMed ID: 30390440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential influenza virus endonuclease inhibitors through virtual screening based on the 3D-QSAR model.
    Kim J; Lee C; Chong Y
    SAR QSAR Environ Res; 2009; 20(1-2):103-18. PubMed ID: 19343586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Baloxavir marboxil: a potent cap-dependent endonuclease inhibitor of influenza viruses].
    Reina J; Reina N
    Rev Esp Quimioter; 2019 Feb; 32(1):1-5. PubMed ID: 30676002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models.
    Fukao K; Ando Y; Noshi T; Kitano M; Noda T; Kawai M; Yoshida R; Sato A; Shishido T; Naito A
    PLoS One; 2019; 14(5):e0217307. PubMed ID: 31107922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PA
    Liu Z; Gu S; Zhu X; Liu M; Cao Z; Qiu P; Li S; Liu S; Song G
    Eur J Med Chem; 2022 Jan; 227():113929. PubMed ID: 34700269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
    Noshi T; Kitano M; Taniguchi K; Yamamoto A; Omoto S; Baba K; Hashimoto T; Ishida K; Kushima Y; Hattori K; Kawai M; Yoshida R; Kobayashi M; Yoshinaga T; Sato A; Okamatsu M; Sakoda Y; Kida H; Shishido T; Naito A
    Antiviral Res; 2018 Dec; 160():109-117. PubMed ID: 30316915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Ye J; Yang X; Xu M; Chan PK; Ma C
    Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel acylhydrazone neuraminidase inhibitors.
    Zhao ZX; Cheng LP; Li M; Pang W; Wu FH
    Eur J Med Chem; 2019 Jul; 173():305-313. PubMed ID: 31022584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
    Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic analysis of baloxavir marboxil, a novel cap-dependent endonuclease inhibitor, in a murine model of influenza virus infection.
    Ando Y; Noshi T; Sato K; Ishibashi T; Yoshida Y; Hasegawa T; Onishi M; Kitano M; Oka R; Kawai M; Yoshida R; Sato A; Shishido T; Naito A
    J Antimicrob Chemother; 2021 Jan; 76(1):189-198. PubMed ID: 33035324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baloxavir marboxil: a novel cap-dependent endonuclease (CEN) inhibitor for the treatment of acute uncomplicated influenza.
    Locke SC; Splawn LM; Cho JC
    Drugs Today (Barc); 2019 Jun; 55(6):359-366. PubMed ID: 31250840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
    Enkhtaivan G; Muthuraman P; Kim DH; Mistry B
    Bioorg Med Chem; 2017 Oct; 25(20):5185-5193. PubMed ID: 28958846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease.
    Rogolino D; Bacchi A; De Luca L; Rispoli G; Sechi M; Stevaert A; Naesens L; Carcelli M
    J Biol Inorg Chem; 2015 Oct; 20(7):1109-21. PubMed ID: 26323352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection.
    Fukao K; Noshi T; Yamamoto A; Kitano M; Ando Y; Noda T; Baba K; Matsumoto K; Higuchi N; Ikeda M; Shishido T; Naito A
    J Antimicrob Chemother; 2019 Mar; 74(3):654-662. PubMed ID: 30476172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.